Hang Seng Index quarterly review results announced: J&T EXPRESS-W(01519), Aluminum Corporation Of China(02600), BeOne Medicines Ltd.(06160) have been added as Hang Seng Index constituents, bringing the total number of constituents to 93.
Glamorous Express-W (01519), Aluminum Corporation of China (02600), and BeiGene (06160) will be included in the Hang Seng Index constituents, increasing the number of constituents from 90 to 93.
On May 22nd, Hang Seng Index Company announced the quarterly review results of the Hang Seng Index Series as of March 31, 2026. All changes will be implemented after the market closes on June 5, 2026 (Friday) and will take effect on June 8, 2026 (Monday). Among them, J&T EXPRESS-W (01519), Aluminum Corporation Of China (02600), BeOne Medicines Ltd. (06160) will be included in the Hang Seng Index constituents, increasing the number of constituents from 90 to 93.
1. Hang Seng Index
J&T EXPRESS-W (01519), Aluminum Corporation Of China (02600), BeOne Medicines Ltd. (06160) will be included in the Hang Seng Index constituents, increasing the number of constituents from 90 to 93.
2. Hang Seng H-Share Index ETF
HANSOH PHARMA (03692), AKESO (09926) will be included in the Hang Seng H-Share Index ETF, while HAIER SMARTHOME (06690) will be removed, maintaining 50 constituents.
3. Hang Seng Tech Index
MINIMAX-W (00100), KNOWLEDGE ATLAS (02513) will be included in the Hang Seng Tech Index, while KINGSOFT (03888) will be removed, maintaining 30 constituents.
4. Hang Seng Composite Index
MINIMAX-W (00100) will be included in the Hang Seng Composite Index constituents, increasing the number of constituents from 531 to 538.
Related Articles
New Stock Outlook | Cutting Costs, Pressuring Costs, Losing Customers Three Major Cracks Behind the Silicon-Based Intelligent Light Ring
Industrial: Compared to the dot-com bubble, where is the current AI market heading?
New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.
New Stock Outlook | Cutting Costs, Pressuring Costs, Losing Customers Three Major Cracks Behind the Silicon-Based Intelligent Light Ring
Industrial: Compared to the dot-com bubble, where is the current AI market heading?
New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.
